DNA Nanogel for Cancer Drug Delivery

  • Author: ChemistryViews.org
  • Published: 20 November 2020
  • Copyright: Wiley-VCH GmbH
  • Associated Societies: American Chemical Society (ACS), USA
thumbnail image: DNA Nanogel for Cancer Drug Delivery

Chemotherapy drugs can kill cancer cells, and thus, save lives. However, they generally affect both cancer cells and healthy cells, which leads to harmful side effects. Methods for the controlled delivery and release of anti-cancer drugs within tumors could help to reduce these side effects.

Teck-Peng Loh, Tianhu Li, Northwestern Polytechnical University (NPU), Xi’an, China, and Nanyang Technological University, Singapore, and colleagues have developed DNA-based nanogels that specifically break down and release their chemotherapeutic contents within cancer cells. The team used cancer biomarkers, i.e., proteins or other components that are present in differing amounts in cancer cells and healthy cells, to trigger the drug release. Specifically, they designed a nanogel that can be degraded by a biomarker called flap endonuclease 1 (FEN1), a repair enzyme that cuts certain types of DNA and is present in larger amounts in cancer cells.

To make the DNA nanogels, the researchers used a DNA backbone that FEN1 can recognize and cut. With cell-free systems, the researchers observed that the DNA-based nanogels were broken down by FEN1, but not by other DNA repair enzymes or compounds. The team incubated live cells with the DNA-based nanogels, and found that healthy cells did not have enough FEN1 to break down the nanogels, but cancer cells did. The chemotherapeutic drugs doxorubicin and vinorelbine were incorporated into the nanogel, and tests showed that cancer cells died at higher rates than healthy cells when in contact with the drug-loaded nanogel.

The work indicates that DNA-based nanogels can introduce chemotherapy drugs into cancer cells with a high specificity, which could reduce the risk of side effects. According to the team, the nanogels also could be used as probes for the biomarkers, which would be useful for cancer diagnostics.



Article Views: 2449

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission and consult our permisson guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH